Martin Wilkins
Imperial College London
H-index: 73
Europe-United Kingdom
Top articles of Martin Wilkins
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Multi-biobank Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension | Benjamin Woolf James A Perry Charles C Hong Martin R Wilkins Mark Toshner | 2024/2/24 | |
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport | Cardiovascular Research | Bin Liu Mujahid Azfar Ekaterina Legchenko James A West Shaun Martin | 2024/4/16 |
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension | Science Translational Medicine | Yi-Yin Tai Qiujun Yu Ying Tang Wei Sun Neil J Kelly | 2024/1/10 |
Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension | European Respiratory Journal | Benjamin Woolf James A Perry Charles C Hong Martin R Wilkins Mark Toshner | 2024/4/1 |
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension | Nature Communications | Anna Ulrich Yukyee Wu Harmen Draisma John Wharton Emilia M Swietlik | 2024/1/6 |
Comparison of contemporary risk scores in all groups of pulmonary hypertension-a PVRI GoDeep meta-registry analysis | Chest | Athiththan Yogeswaran Henning Gall Meike Fünderich Martin R Wilkins Luke Howard | 2024/3/19 |
Therapeutic Implications of Plasma Proteome Clusters in Pulmonary Hypertension | A Boucly LS Howard MJC Humbert O Sitbon D Wang | 2024/5 | |
Sex-specific genetic determinants of right ventricular structure and function | medRxiv | Lars Harbaum Jan K Hennigs Julian Pott Jonna Ostermann Christoph Sinning | 2024 |
Mendelian randomization study with clinical follow‐up links metabolites to risk and severity of pulmonary arterial hypertension | Journal of the American Heart Association | Elham Alhathli Thomas Julian Zain Ul Abideen Girach AA Roger Thompson Christopher Rhodes | 2024/3/19 |
A Monoclonal Antibody Targeting the ZIP12 Transporter Attenuates Severe Experimental Pulmonary Arterial Hypertension | SJ Hopley C-N Chen C Xie N Baxan M Niglas | 2024/5 | |
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy … | Pulmonary Circulation | Frances Varian Jennifer Dick Christian Battersby Stefan Roman Jenna Ablott | 2024/1 |
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism | American Journal of Respiratory and Critical Care Medicine | James Liley Michael Newnham Marta Bleda Katherine Bunclark William Auger | 2024/3/12 |
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension | J Hong L Medzikovic W Sun G Ruffenach B Wong | 2024/5 | |
Novel insights into cardiovascular ageing in the general population using machine learning | European Journal of Preventive Cardiology | M Shah M H De A Inacio C Lu PR Schiratti SL Zheng | 2023/6 |
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study | The Lancet Respiratory Medicine | Callum Jackson Iain D Stewart Tatiana Plekhanova Peter S Cunningham Andrew L Hazel | 2023/8/1 |
Restoration of Foxp3+ Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology | American Journal of Respiratory and Critical Care Medicine | Chien-Nien Chen Nabil Hajji Fu-Chiang Yeh Sunniyat Rahman Souad Ali | 2023/10/15 |
Response by Walters et al to Letter Regarding Article, “SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary … | Circulation | Rachel Walters Eleni Vasilaki Martin R Wilkins Lan Zhao Christopher J Rhodes | 2023/11/28 |
Cardiovascular medicine: towards a molecular classification of pulmonary hypertension | Martin Wilkins | 2023 | |
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study | EClinicalMedicine | Hamish JC McAuley Rachael A Evans Charlotte E Bolton Christopher E Brightling James D Chalmers | 2023/3/1 |
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls | The Lancet Regional Health–Europe | Bang Zheng Giulia Vivaldi Luke Daines Olivia C Leavy Matthew Richardson | 2023/6/1 |
